Unknown PHASE3 INTERVENTIONAL 2-arm NCT02613780

Refractive Treatment of Early Keratoconus

iDesign Aberrometer for the Refractive Treatment of Early Keratoconus

Sponsor: Abbott Medical Optics

Interventions Crosslinking Photorefractive keratectomy iDesign® Advanced WaveScan Studio

Updated 6 times since 2017 Last updated: Dec 11, 2015 Started: Jan 31, 2016 Primary completion: Jan 31, 2017 Completion: Jan 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Keratoconus and is currently ongoing. Abbott Medical Optics leads this study, which shows 6 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Feb 2019 — Jan 2021 [monthly]

Unknown Status PHASE3

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Feb 2019 [monthly]

Not Yet Recruiting PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE3

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abbott Medical Optics
Ottawa Hospital Research Institute

Data source: Ottawa Hospital Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.